文献速递脑血管病外科神经重症

动静脉畸形的治愈性栓塞治疗

Curative Embolization of Arteriovenous Malformations.
PubMed 文献 · World Neurosurg · 2019-02-05

动静脉畸形有显著的累积出血风险,治疗选择取决于畸形团大小、位置、静脉引流模式、手术可及性、破裂状态和既往治疗。Spetzler-Martin分级是选择治疗最常用的分类系统,I和II级适合单纯手术切除,III级多采用术前栓塞后显微手术切除的多模式治疗,IV和V级一般观察除非破裂。治愈性栓塞是近几十年出现的理念,近年来其安全性和有效性的临床证据不断增加。

要点

  • Spetzler-Martin分级是选择动静脉畸形治疗最常用的分类系统。
  • I和II级病变适合单纯手术切除,III级多采用术前栓塞后显微手术切除。
  • IV和V级病变一般观察,除非破裂。

核心结论

  • 治愈性动静脉畸形栓塞是近几十年出现的理念,近年来其安全性和有效性的临床证据不断增加。
  • 血管内技术和技术的创新将提高治愈性动静脉畸形栓塞的闭塞率。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 动静脉畸形有显著的累积出血风险。
  • 治疗选择取决于畸形团大小、位于功能区与非功能区、静脉引流模式、手术可及性、破裂状态和既往治疗。
  • Spetzler-Martin分级是选择治疗最常用的分类系统。
  • I和II级病变适合单纯手术切除,III级病变多采用术前栓塞后显微手术切除的多模式治疗,IV和V级病变一般观察除非破裂。
  • 栓塞治疗动静脉畸形最常用作术前辅助,偶尔用作放射外科前辅助。

关键数值与推荐

  • Spetzler-Martin分级:I和II级病变适合单纯手术切除;III级病变多采用术前栓塞后显微手术切除的多模式治疗;IV和V级病变一般观察,除非破裂。

临床怎么用

  • 栓塞治疗动静脉畸形最常用作术前辅助,偶尔用作放射外科前辅助。
  • 原文未据此给出治愈性栓塞的推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Arteriovenous malformations have a significant cumulative risk for hemorrhage. Treatment options include observation, microsurgical resection, stereotactic radiosurgery, embolization, and multimodal treatment. Treatment selection and timing are based on arteriovenous malformation (AVM) features including size, location in eloquent versus noneloquent parenchyma, pattern of venous drainage, surgical access, rupture status, and previous treatments. Spetzler-Martin grading is the most commonly used classification system used to select treatment, with grades I and II lesions amenable to surgical resection alone, grade III lesions typically treated via a multimodal approach entailing preoperative embolization followed by microsurgical resection, and grades IV and V lesions generally observed unless ruptured. Embolization in the treatment of AVMs is thus most commonly used as a preoperative or, occasionally, preradiosurgical adjunct. The concept of curative AVM embolization is an attractive one that has emerged within the past few decades, with increasing clinical evidence for its safety and efficacy in recent years. Obliteration rates for curative AVM embolization will be improved by innovation in endovascular techniques and technologies.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zaki Ghali MG, Kan P, Britz GW, et al. Curative Embolization of Arteriovenous Malformations. World Neurosurg. 2019. PMID: 30735875. doi:10.1016/j.wneu.2019.01.166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。